The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective observational study to evaluate lemborexant utility in insomnia among women with breast cancer (WJOG14921B, LUNAR study).
 
Yukinori Ozaki
Honoraria - Chugai Pharma; Daiichi Sankyo Pharmaceutical; Kyowa Kirin; Lilly O.; Pfizer
 
Mari Hosonaga
No Relationships to Disclose
 
Manabu Futamura
No Relationships to Disclose
 
Sasagu Kurozumi
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo Pharmaceutical; Dinow; Eisai; Kyowa Kirin; Lilly O.; MSD; Novartis; Taiho Pharmaceutical; Takeda
 
Takuma Onoe
No Relationships to Disclose
 
Tsutomu Iwasa
No Relationships to Disclose
 
Hidenori Kamio
No Relationships to Disclose
 
Kaori Terata
Speakers' Bureau - AstraZeneca; Chugai Pharma; Daiichikyo; Pfizer
 
Rurina Watanuki
No Relationships to Disclose
 
Hiroko Masuda
Honoraria - Eisai
 
Yoshinori Saeki
No Relationships to Disclose
 
Shigehisa Kitano
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Janssen; Lilly Japan; Merck KGaA; MSD; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; GlaxoSmithKline; ImmuniT Research Inc.; Ono Pharmaceutical; Rakuten Medical; Sumitomo Dainippon Pharma; United Immunity
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim; Boehringer Ingelheim (Inst); Chugai Pharma; Chugai Pharma (Inst); Daiichi Sankyo; Daiichi Sankyo (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Loxo/Lilly (Inst); MSD (Inst); Ono Pharmaceutical; Ono Pharmaceutical (Inst); Pfizer (Inst); Takara Bio; Takeda (Inst)
 
Kentaro Sakamaki
No Relationships to Disclose
 
Kiyomi Nonogaki
Employment - Ono Pharmaceutical (I)
 
Yuta Yoshimura
Employment - Eisai
 
Daisuke Kawai
Employment - Eisai
 
Toshimi Takano
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly